Publications by authors named "William Cromwell"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,923,737

Total Likes

40,135

Extended Reach

5,395,891

Social Features

382
P
Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data.
Kelly D Myers, Joshua W Knowles, David Staszak, Michael D Shapiro, William Howard, William C Cromwell

Lancet Digit Health· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding.
Allan D Sniderman, Patrick Couture, Seth S Martin, Jacqueline DeGraaf, Patrick R Lawler, William C Cromwell

J Lipid Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Achieving Targets of Low-Density Lipoprotein Particle Number Versus Low-Density Lipoprotein Cholesterol Level.
Michael Grabner, Deborah A Winegar, Rajeshwari S Punekar, Ralph A Quimbo, Mark J Cziraky, William C Cromwell

Am J Cardiol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
David M Tehrani, Yanglu Zhao, Michael J Blaha, Samia Mora, Rachel H Mackey, William Cromwell

Am J Cardiol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia.
Raul D Santos, Frederick J Raal, Joanne M Donovan, William C Cromwell

J Clin Lipidol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
Gregory S Thomas, William C Cromwell, Shariq Ali, Wai Chin, JoAnn D Flaim

J Am Coll Cardiol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-directed mutations in the lanthipeptide mutacin 1140.
Shaorong Chen, Shawanda Wilson-Stanford, William Cromwell, Jeffrey D Hillman, Adam Guerrero

Appl Environ Microbiol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of low-density lipoprotein particles and apolipoprotein B in patients with cardiovascular risk.
Jennifer L Ennis, William C Cromwell

J Fam Pract· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.
Michael H Davidson, Christie M Ballantyne, Terry A Jacobson, Vera A Bittner, Lynne T Braun, William C Cromwell

J Clin Lipidol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
Anne C Goldberg, Paul N Hopkins, Peter P Toth, Christie M Ballantyne, Daniel J Rader, William C Cromwell

J Clin Lipidol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
Anne C Goldberg, Paul N Hopkins, Peter P Toth, Christie M Ballantyne, Daniel J Rader, William C Cromwell

J Clin Lipidol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future issues, public policy, and public awareness of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
Anne C Goldberg, Jennifer G Robinson, William C Cromwell, Joyce L Ross, Paul E Ziajka

J Clin Lipidol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.
Frederick J Raal, Raul D Santos, Dirk J Blom, A David Marais, Min-Ji Charng, William C Cromwell

Lancet· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-density lipoprotein and apolipoprotein B: clinical use in patients with coronary heart disease.
William C Cromwell, Thomas A Barringer

Curr Cardiol Rep· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterial age as a function of coronary artery calcium.
Thomas Barringer, William Cromwell

Am J Cardiol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.
William C Cromwell, James D Otvos, Michelle J Keyes, Michael J Pencina, Lisa Sullivan

J Clin Lipidol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-density lipoprotein associations with coronary heart disease: Does measurement of cholesterol content give the best result?
William C Cromwell

J Clin Lipidol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.
Elias J Jeyarajah, William C Cromwell, James D Otvos

Clin Lab Med· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl.
William C Cromwell, James D Otvos

Am J Cardiol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement issues related to lipoprotein heterogeneity.
James D Otvos, Elias J Jeyarajah, William C Cromwell

Am J Cardiol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis